Академический Документы
Профессиональный Документы
Культура Документы
INDEX
ADVANCE
DECLINE
UNCHANGED
NSE
617
837
60
INDEX
ADVANCE
DECLINE
UNCHANGED
BSE
1214
1457
165
Gainers
LARGECAP
BPCL
IDEA
ICICIBANK
POWER GRID
TATAMTRDVR
Losers
LARGECAP
HUL
INDUSINDBANK
YESBANK
EICHERMOTOR
AXISBANK
%CHANG
E
2.88%
2.36%
2.18%
1.96%
1.91%
%CHANG
E
-2.91%
-2.10%
-1.80%
-1.22%
-0.97%
MIDCAP
CANBANK
HPCL
IOC
BHARATFIN
PIRAMAL ENT
MID CAP
MINDTREE
M&MFIN
EXIDEIND
RAJESHEXPO
DLF
%CHANG
E
4.88%
4.54%
4.42%
2.98%
2.92%
%CHANG
E
-8.57%
-2.17%
-2.01%
-1.98%
-3.49%
Nifty
Indian Markets
INDEX
VALUE
CHANGE
%CHANG
E
+0.23%
+0.15%
-0.10%
NIFTY
8528.55
+19.85
SENSEX
27787.62
+40.96
BANKNIFT
18905.15
-18.25
Y
INDIA VIX
15.7950
-0.19
-1.20%
International Markets
INDEX
VALUE
CHANGE
%CHANGE
DOW
18533.05
+16.50
+0.09%
NASDAQ
5055.78
+26.19
+0.52%
FTSE
6666.34
-29.08
-0.44%
SHANGHA 3036.20
-7.36
-0.04%
I
NIKKEI
16723.31
+225.46
+1.35%
OUR PREVIOUS CALLS UPDATE
Intraday super stars
Date
Stocks
19/07/1 DISHTV
6
19/07/1 DLF
6
Multibagger
Date
Stock
18/07/1
ARVIND
6
Trifid special
Date
Stock
13/07/1 ULTRACEM
6
O
Entry
95.70
Exit
94.70
P/L
2090
152.75
151.25
1964
Entry
Exit
P/L
317.10
315.10
5000
Entry
3485
Exit
3554
P/L
5940
Stock
Snippets
UltraTech Cement gains and hits fresh high on NSE as
operational numbers beat analysts' expectations. Net profit up
by 26.2% to Rs 757.6 crore led by operational income and
higher other income despite sharp jump in tax cost. Revenue
up by 3.8 percent to Rs 6232.5 crore from Rs 6007 crore for
the same quarter last year.
Exide Industries shares tanks despite company posted 26
percent jump in net profit which stood at Rs 196.05 crore for
its quarter first against Rs 155.71 crore compared on yearly
basis driven by higher sales.
MindTree shares tanks and hits fresh low on NSE today after
Q1 profit misses estimates, Profit for Q1 dips 7.1% to Rs
123.5 crore while Revenue up slightly from Rs 1320.3 crore to
Rs 1327.6 crore. Revenue in dollar term also increased by
1.7% to USD 199 million from USD 195.6 million compared on
Q-o-Q.
Sun Pharma and SPARC (Sun Pharma Advanced Research
Company) announced a licensing arrangement for SPARC's
ELEPSIA XR (Levetiracetam ER Tablets). As per arrangement,
SPARC will license ELEPSIA XR (Levetiracetam Extended
Release tablets) to a wholly-owned subsidiary of Sun Pharma
for the US market.
Global Markets
Japan's Nikkei share average rose for a sixth straight day on
Tuesday to a near six-week high, with a sagging yen and Wall
Street's rise to a fresh record boosting investors' appetite for
riskier assets.
DATE: 19/07/16
FII/DII
CASH
FII
548.9
DII
-377.43
MTD
9681.76
2798.76
YTD
7094.26
274.96
%CHANGE IN
MARKETCAP
ADV.
DEC
.
1.78%
13
11
0.76%
17
19
0.62%
0.61%
0.53%
36
31
14
59
46
13
0.45%
0.41%
0.38%
50
41
41
73
41
60
0.38%
13
15
0.36%
0.26%
0.21%
0.07%
38
80
37
2
48
104
45
2
-0.18%
62
99
-0.37%
-0.37%
-0.42%
6
45
23
6
64
55
-0.44%
-0.45%
-0.58%
21
6
31
29
9
47
-1.24%
12
14
(Premium Section)
(Premium
Section)
AMBUJACEM EQ sustained above on higher levels after surpassing the important resistance on daily charts
and now is expected to give breakout from upper consolidation.
BUY ABOVE 265 TARGETS 267.65/270.30/271 SL 261.50.
CAIRN EQ has been hovering around the strict resistance on daily charts and also closed near to it in the
previous session suggesting northward movement in the coming session.
BUY ABOVE 177.20 TARGETS 179/180.80/182.60 SL 174.50.
(Premium
Section)
ITC FUTURE closed on a flat note on daily charts but above the upper band of triangle pattern and so buying
momentum is expected in this stock.
BUY ABOVE 250.25 TARGETS 251.50 /252.80 SL 249.10.
(Premium Section)
KOTAKBANK EQ had been hovering around its all time highs since last four sessions and now is expected to surge
above the immediate resistance so made on daily charts.
BUY ABOVE 784 TARGET 800 SL 770.
Nifty traded volatile today and witnessed selling pressure from the mark of 8555 and ended the session with a
hammer on daily charts. 8400 is a good demand area for the index while there is a strong supply zone at 8600
level.
Bank Nifty Technicals
Bank nifty also traded volatile following the nifty and witnessed selling pressure from the days high ending the
session with a dozi on daily charts. 19176 is a key resistance for the banking index while 18580 is a good supply
area.
Index
18-July-16
19-July-16
Change in OI
%Chg
NIFTY
22379700
22899075
519375
2.32
18/07/16 (Mon)
Results,
Exide Industries,
Hindustan Unilever,
MindTree
Previous High
2148.95
2763
232.86
788.80
630.75
52W High
265
784
505
1044.90
426.80
Previous Low
1300
60.40
154.35
603.95
41.90
52W Low
875.10
706.40
421
100.65
98.75
23/07/16(Sat)
Results
Havells,
Mphasis
Trifid Research respects and values the Right to Policy of each and every individual. We are
esteemed by the relationship and by becoming our clients; you have a promise from our side
that we shall remain loyal to all our clients and non-clients whose information resides with us.
This Privacy Policy of Trifid Research applies to the current clients as well as former clients.
Below are the word by word credentials of our Privacy Policy:
1. Your information, whether public or private, will not be sold, rented, exchanged,
transferred or given to any company or individual for any reason without your consent.
2. The only use we will be bringing to your information will be for providing the services to
you for which you have subscribed to us.
3. Your information given to us represents your identity with us. If any changes are brought
in any of the fields of which you have provided us the information, you shall bring it to
our notice by either calling us or dropping a mail to us.
4. In addition to the service provided to you, your information (mobile number, E-mail ID
etc.) can be brought in use for sending you newsletters, surveys, contest information, or
information about any new services of the company which will be for your benefit and
while subscribing for our services, you agree that Trifid Research has the right to do so.
5. By subscribing to our services, you consent to our Privacy Policy and Terms of Use.
6. Trifid research does not guarantee or is responsible in any which way, for the trade
execution of our recommendations, this is the sole responsibility of the client.
7. Due to the markets volatile nature, the trader may/ may not get appropriate opportunity
to execute the trades at the mentioned prices and Trifid Research holds no liability for
any profit/ loss incurred whatsoever in this case.
8. It is the responsibility of the client to view the report timely from our Premium member
section on our website: www.trifidresearch.com and the same will also be mailed to this
registered email id.
9. Trifid research does not hold any liability or responsibility of delay in mail delivery of
reports, as this depends on our mail service providers network infrastructure.
10. The clients can call us for any query related to buying/selling the securities, based on
our recommendations.